| | | | |
| | RegenMD | | |
| | | | |
| | | | |
| | | By Leith Dunick, tbnewswatch.com Getting a provincial Class D tissue bank designation has researchers at the Lake Superior Centre for Regenerative Medicine saying the sky is the limit when it comes to their future. Officials at the not-for-profit ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | | |
| |
| | | | |
| | | | |
| | | Regenerative medicine firm Tengion reports losses of nearly $26 million in 2010, down from nearly $32 million in 2009. Tengion, an early-stage company working to commercialize the regenerative medicine research of Wake Forest University's Dr. Anthony ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | She is the Donald E. and Delia B. Baxter professor and director of the Baxter Laboratory for Stem Cell Biology in the microbiology and immunology department, at the Stanford Institute for Stem Cell Biology and Regenerative Medicine at the Stanford ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | | |
| |
| | | | |
| | | | |
| | | In a conference call with stock analysts Friday morning, CEO Dr. Steven Nichtberger said the $31.4 million private stock sale completed earlier this month has given the East Norriton regenerative medicine company enough cash to fund operations into ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | | |
| |
| | | | |
| | | | |
| | | | |
| |
| | | | |
| | | | |
| | | Adipose-derived mesenchymal stem cells in collagen-hyaluronic acid gel composite scaffolds for vocal fold regeneration. Ann Otol Rhinol Laryngol. 2011 Feb;120(2):123-30 Authors: Xu W, Hu R, Fan E, Han D We sought to characterize the changes in the extracellular matrix (ECM) of the lamina propria following the implantation of autologous adipose-derived mesenchymal stem cells (ADSCs) in composite scaffolds in a rabbit vocal fold wound model. PMID: 21391425 [PubMed - indexed for MEDLINE] | | | | | |
| |
| | | | |
| | | | |
| | | | |
| |
| | | | |
| | | | |
| | | Advanced Cell Technology, Inc. (ACT) a leader in the field of regenerative medicine, announced that China's State Intellectual Property Office (SIPO) has allowed the company's patent application to provide broad intellectual property protection in ... See all stories on this topic » | | | | | |
| |
| | | | |
No comments:
Post a Comment